SCHEDULE: Weiss Asset Management Exits scPharmaceuticals Stake

Sentiment:

Beneficial Ownership Amendment 11 February 2026 3:06 PM

Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss report zero beneficial ownership in scPharmaceuticals Inc. common stock.

Worse than expectedWeiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss now report 0% beneficial ownership, indicating a complete divestment of their previous stake in scPharmaceuticals Inc.This action by a notable institutional investor suggests a potential loss of confidence or a strategic reallocation of capital away from the company.

Summary

Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss have filed an Amendment No. 1 to their Schedule 13G for scPharmaceuticals Inc.
The reporting persons collectively hold 0.00 shares of scPharmaceuticals Inc. common stock, representing 0.0% of the class.
This filing indicates a complete divestment of their previously reported beneficial ownership in the company.
The beneficial ownership is reported as of December 31, 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative signal for scPharmaceuticals Inc., as a prominent institutional investor has fully divested its stake, potentially indicating a lack of confidence in the company's near-term prospects or a strategic shift.

Negatives

Reporting persons, including Weiss Asset Management LP, now hold 0.0% of scPharmaceuticals Inc. common stock, indicating a complete divestment of their stake.

Future Outlook

Industry Context

StockSavvy.ai notes that a complete divestment by a significant institutional investor like Weiss Asset Management could signal a re-evaluation of scPharmaceuticals Inc.'s prospects or a strategic reallocation of capital within the pharmaceutical sector. Such moves are often influenced by factors like clinical trial outcomes, regulatory hurdles, or competitive landscape shifts.

Stakeholder Impact

Shareholders may perceive the complete divestment by a significant institutional investor as a negative indicator, potentially leading to decreased investor confidence and downward pressure on the stock price.

Key Dates

Date	Description
12/31/2025	Date of event requiring filing of this statement, indicating the reporting period end for beneficial ownership.
02/11/2026	Signature date for Weiss Asset Management LP, WAM GP LLC, and Andrew M. Weiss.

Recommendation

sell

The complete divestment by Weiss Asset Management, a sophisticated institutional investor, signals a significant re-evaluation of scPharmaceuticals Inc.'s investment viability. This move often reflects a lack of conviction in the company's future performance or a strategic shift in the investor's portfolio, suggesting other investors consider exiting their positions.

Keywords

scPharmaceuticals Inc., Weiss Asset Management, Schedule 13G, beneficial ownership, institutional ownership, equity stake, divestment, pharmaceuticals

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.